The AI drug discovery unicorn aims to move beyond early research and build fully autonomous intelligence for real-world clinical development.
Beijing, 4 February 2026 – Deep Intelligent Pharma,...
How a new Pfizer, Walgreens collaboration is helping people stay protected with simple, personal healthcare
New York, January 2026 – Winter is often the busiest season of the...
The investment will support advanced human-like cell models for neuroscience, eye, and heart research.
Edinburgh, Scotland, 14 January 2026 - Axol Bioscience Ltd. (Axol), a leading company in...
From rapid FDA approvals to AI-powered diagnostics and major metabolic partnerships, life sciences innovation is accelerating across drugs, devices, and regulation.
New York, US, 13 December 2025 –...
A major milestone brings faster, smarter, and more flexible glucose monitoring to people living with type 1 diabetes.
Minneapolis, Minnesota, 4 December 2025 – Medtronic has officially launched...
New funding accelerates AI-driven research expansion and brings clinical trials closer to patients everywhere
Columbus, Ohio & New York, 4 December 2025 – Paradigm Health, a fast-growing technology...
Princeton Biopartners, a leading consultancy in Integrated Evidence Generation Planning and Medical Affairs strategy, has officially announced the launch of EVEXA®, which happens to be a groundbreaking...
Center for Information and Study on Clinical Research Participation (CISCRP) has officially published a landmark article named "Considerations for the Use of Artificial Intelligence in the Creation...
TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, has officially announced the release...
